Myriad Genetics, Inc. (FRA:MYD)
6.25
+0.05 (0.81%)
At close: Dec 5, 2025
Myriad Genetics Market Cap
Myriad Genetics has a market cap or net worth of €568.10 million as of December 5, 2025. Its market cap has decreased by -56.66% in one year.
Market Cap
568.10M
Enterprise Value
625.60M
Revenue
703.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.25
Market Cap Chart
Since October 6, 1995, Myriad Genetics's market cap has increased from 132.55M to 568.10M, an increase of 328.59%. That is a compound annual growth rate of 4.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |